Atlas Trials

Development of Multi-specific Antibodies Based on Immune Microenvironment of Breast Cancer

Clinical trial NCT05767931 · UNKNOWN

Trial details

NCT number
NCT05767931
Sponsor
Peking University
Status
UNKNOWN
Study type
OBSERVATIONAL
Invasive Breast Cancer
Start date
2023-03-06
Primary completion
2024-11-06
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.